Click here to return to the home page.
The Leukemia/Bone Marrow Transplant Program of BC

Chemotherapy Drugs

Alemtuzumab (CAMPATH)

Alemtuzumab (uh-lem-TOOZ-uh-mab) is a drug that is used to treat many types of cancer. It is a monoclonal antibody, a type of protein designed to target and kill cancer cells. It is a clear liquid that is injected into a vein.

Common Side Effects

  • A flu-like illness may occur shortly after your first treatment with alemtuzumab and with each increase in dose.
  • Fever and chills frequently occur.
  • Nausea and vomiting may sometimes occur. It may last for 24 hours.
  • Dizziness and headache may sometimes occur.
  • Muscle or joint pain may sometimes occur.
  • Numbness or tingling of the fingers or toes may occur. This will slowly return to normal once your treatment is over. It may take up to several months.
  • Hair loss does not occur with alemtuzumab.

Printable Drug Information

Click here, to view and print a complete description of alemtuzumab and its side effects and management from the BC Cancer Agency Drug Manual©.

^ Top